15-Year comparison of supra-annular porcine and PERIMOUNT aortic bioprostheses

Asian Cardiovascular and Thoracic Annals

Volumn 14, Issue 3, 2006, Pages 200-205

  Jamieson, W R Eric ^a,c   Germann, Eva ^a   Aupart, Michel R ^b   Neville, Paul H ^b   Marchand, Michel A ^b   Fradet, Guy J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITÉ DE TOURS   (France)

^c ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PROSTHESIS FAILURE; SEX DIFFERENCE; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 33745025259     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230601400306     Document Type: Article

References (18)

1. Frater RW, Furlong P, Cosgrove DM, Okies JE, Colburn LQ, Katz AS, et al. Long-term durability and patient functional status of the Carpentier-Edwards PERIMOUNT pericardial bioprosthesis in the aortic position. J Heart Valve Dis 1998;7:48-53.
2. Aupart MR, Sirinelli AL, Diemont FF, Meurisse YA, Dreyfus XB, Marchand MA. The last generation of pericardial valves in the aortic position: ten-year follow-up in 589 patients. Ann Thorac Surg 1996;61:615-20.
3. Neville PH, Aupart MR, Diemont FF, Sirinelli AL, Lemoine EM, Marchand MA. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience. Ann Thorac Surg 1998;66(6 Suppl):S143-7.
4. Banbury MK, Cosgrove DM 3rd, White JA. Blackstone EH, Frater RW, Okies JE. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2001;72:753-7.
5. Dellgren G, David TE, Raanani E, Armstrong S, Ivanov J, Rakowski H. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. J Thorac Cardiovasc Surg 2002:124:146-54.
6. Poirier NC, Pelletier LC, Pellerin M, Carrier M. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg 1998;66(6 Suppl):S57-61.
7. Jamieson WR, Janusz MT, Burr LH, Ling H, Miyagishima RT, Germann E. Carpentier-Edwards supra-annular porcine bioprosthesis: second-generation prosthesis in aortic valve replacement. Ann Thorac Surg 2001;71(5 Suppl):S224-7.
8. Jamieson WR, Burr LH, Mivagishima RT, Germann E, MacNab JS, Stanford E, et al. Carpentier-Edwards supra-annular aortic porcine bioprosthesis: clinical performance over 20 years. J Thorac Cardiovasc Surg 2005;130:994-1000.
9. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 1996;62:932-5.
10. Grunkemeier GL, Jamieson WR, Miller DC, Starr A. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovasc Surg 1994;108:709-18.
11. Jamieson WR, Burr LH, Miyagishima RT, Germann E, Anderson WN. Actuarial versus actual freedom from structural valve deterioration with the Carpentier-Edwards porcine bioprostheses. Can J Cardiol 1999;15:973-8.
12. Jamieson WR, Miyagishima RT, Burr LH, Lichtenstein SV, Fradet GJ, Janusz MT. Carpentier-Edwards porcine bioprostheses: clinical performance assessed by actual analysis. J Heart Valve Dis 2000;9:530-5.
13. David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001;121:268-77.
14. Rizzoli G, Bottio T, Thiene G, Toscano G, Casarotto D. Long-term durability of the Hancock II porcine bioprosthesis. J Thorac Cardiovasc Surg 2003;126:66-74.
15. Jamieson WR, Fradet GJ, MacNab JS, Burr LH, Stanford EA, Janusz MT, et al. Medtronic mosaic porcine bioprosthesis: investigational center experience to six years. J Heart Valve Dis 2005;14:54-63.
16. Myken P, Bech-Hanssen O, Phipps B, Caidahl K. Fifteen years follow up with the St. Jude Medical Biocor porcine bioprosthesis. J Heart Valve Dis 2000;9:415-22.
17. Jamieson WR, David TE, Feindel CM, Miyagishima RT, Germann E. Performance of the Carpentier-Edwards SAV and Hancock-II porcine bioprostheses in aortic valve replacement. J Heart Valve Dis 2002;11:424-30.
18. Jamieson WR, Janusz MT, MacNab J, Henderson C. Hemodynamic comparison of second- and third-generation stented bioprostheses in aortic valve replacement. Ann Thorac Surg 2001;71(5 Suppl):S282-4.